These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 35679363)

  • 1. Animal Models of Dysregulated Cardiac Metabolism.
    Bugger H; Byrne NJ; Abel ED
    Circ Res; 2022 Jun; 130(12):1965-1993. PubMed ID: 35679363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes.
    Kolwicz SC; Purohit S; Tian R
    Circ Res; 2013 Aug; 113(5):603-16. PubMed ID: 23948585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets.
    Fukushima A; Milner K; Gupta A; Lopaschuk GD
    Curr Pharm Des; 2015; 21(25):3654-64. PubMed ID: 26166604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylation control of cardiac fatty acid β-oxidation and energy metabolism in obesity, diabetes, and heart failure.
    Fukushima A; Lopaschuk GD
    Biochim Biophys Acta; 2016 Dec; 1862(12):2211-2220. PubMed ID: 27479696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear receptor signaling and cardiac energetics.
    Huss JM; Kelly DP
    Circ Res; 2004 Sep; 95(6):568-78. PubMed ID: 15375023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac Energy Metabolism in Heart Failure.
    Lopaschuk GD; Karwi QG; Tian R; Wende AR; Abel ED
    Circ Res; 2021 May; 128(10):1487-1513. PubMed ID: 33983836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of YAP/TAZ in Energy Metabolism in the Heart.
    Kashihara T; Sadoshima J
    J Cardiovasc Pharmacol; 2019 Dec; 74(6):483-490. PubMed ID: 31815864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart spotting.
    el Azzouzi H; De Windt LJ
    Basic Res Cardiol; 2008 May; 103(3):228-31. PubMed ID: 18274799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 'Goldilocks zone' of fatty acid metabolism; to ensure that the relationship with cardiac function is just right.
    Kerr M; Dodd MS; Heather LC
    Clin Sci (Lond); 2017 Aug; 131(16):2079-2094. PubMed ID: 28739841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart.
    Jaswal JS; Keung W; Wang W; Ussher JR; Lopaschuk GD
    Biochim Biophys Acta; 2011 Jul; 1813(7):1333-50. PubMed ID: 21256164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energy metabolism in cardiac remodeling and heart failure.
    Azevedo PS; Minicucci MF; Santos PP; Paiva SA; Zornoff LA
    Cardiol Rev; 2013; 21(3):135-40. PubMed ID: 22990373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting myocardial substrate metabolism in heart failure: potential for new therapies.
    Ardehali H; Sabbah HN; Burke MA; Sarma S; Liu PP; Cleland JG; Maggioni A; Fonarow GC; Abel ED; Campia U; Gheorghiade M
    Eur J Heart Fail; 2012 Feb; 14(2):120-9. PubMed ID: 22253453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
    Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
    Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.
    Doenst T; Pytel G; Schrepper A; Amorim P; Färber G; Shingu Y; Mohr FW; Schwarzer M
    Cardiovasc Res; 2010 Jun; 86(3):461-70. PubMed ID: 20035032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioenergetics of the failing heart.
    Ventura-Clapier R; Garnier A; Veksler V; Joubert F
    Biochim Biophys Acta; 2011 Jul; 1813(7):1360-72. PubMed ID: 20869993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic db/db mice do not develop heart failure upon pressure overload: a longitudinal in vivo PET, MRI, and MRS study on cardiac metabolic, structural, and functional adaptations.
    Abdurrachim D; Nabben M; Hoerr V; Kuhlmann MT; Bovenkamp P; Ciapaite J; Geraets IME; Coumans W; Luiken JJFP; Glatz JFC; Schäfers M; Nicolay K; Faber C; Hermann S; Prompers JJ
    Cardiovasc Res; 2017 Aug; 113(10):1148-1160. PubMed ID: 28549111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Energetics and metabolism in the failing heart: important but poorly understood.
    Turer AT; Malloy CR; Newgard CB; Podgoreanu MV
    Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):458-65. PubMed ID: 20453645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of Myocardial Hypoxia-Inducible Factor-1α Compromises Metabolic Adaptation and Impairs Cardiac Function in Patients With Cyanotic Congenital Heart Disease During Puberty.
    Liu Y; Luo Q; Su Z; Xing J; Wu J; Xiang L; Huang Y; Pan H; Wu X; Zhang X; Li J; Yan F; Zhang H
    Circulation; 2021 Jun; 143(23):2254-2272. PubMed ID: 33663226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?
    van Bilsen M; Smeets PJ; Gilde AJ; van der Vusse GJ
    Cardiovasc Res; 2004 Feb; 61(2):218-26. PubMed ID: 14736538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling substrate fluxes in the isolated working mouse heart using 13C-labeled substrates: focusing on the origin and fate of pyruvate and citrate carbons.
    Khairallah M; Labarthe F; Bouchard B; Danialou G; Petrof BJ; Des Rosiers C
    Am J Physiol Heart Circ Physiol; 2004 Apr; 286(4):H1461-70. PubMed ID: 14670819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.